Rheumatoid Arthritis

A Glimpse Into the Future of Rheumatology

David Pisetsky MD, new President-elect of the US Bone and Joint Initiative, is likely to be influential  in defining the path of rheumatology in coming years. Listen here as he speaks about the role of rheumatologists in a patient-centered, multidisciplinary medical future.

Rheumatoid Arthritis

About half of rheumatoid arthritis patients don't understand enough information to make intelligent treatment choices. Here's how to help.

A new meta-analysis shows RA treatments have varied effects on patients’ response to flu and pneumonia vaccines.

With some historical analysis, a British rheumatologist unearths a persuasive explanation for the emergence of rheumatoid arthritis when and where it did, in fact, arise.

Biologics have added a decade to the lifespan of rheumatoid arthritis patients since only the start of this century. The impact of age on that treatment has been a subject of intense study.

An online survey suggests that rheumatoid arthritis (RA) patients want quicker, less frequent treatments even if the trade-offs are adverse reactions or less efficacy.

(EULAR2014) Which candidate biologics for rheumatology are destined to pass "Go" and collect? A member of the audience at the recent conference presents his observations and comments.

Comparison of inflamed and non-inflamed synovium provide support for targeting a receptor for a molecule that stimulates granulocytes in rheumatoid and psoriatic arthritis.


Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.